Literature DB >> 27932055

Understanding women's hesitancy to undergo less frequent cervical cancer screening.

Mary A Gerend1, Melissa A Shepherd2, Emily A Kaltz3, Whitney J Davis4, Janet E Shepherd5.   

Abstract

Inappropriate cervical cancer screening (e.g., screening too often) can result in unnecessary medical procedures, treatment, and psychological distress. To balance the benefits and harms, cervical cancer screening guidelines were recently modified in favor of less frequent screening (i.e., every 3 to 5 years). This study investigated women's acceptance of less frequent cervical cancer screening and their primary concerns about extending the screening interval beyond one year. A national sample of 376 U.S. women ages 21-65 completed an online survey in 2014. Predictors of willingness to get a Pap test every 3 to 5 years were identified using logistic regression. We also examined perceived consequences of less frequent screening. Over two thirds were willing to undergo less frequent screening if it was recommended by their healthcare provider. Nevertheless, nearly 20% expressed discomfort with less frequent screening and 45% were either in opposition or unsure whether they would be comfortable replacing Pap testing with primary HPV testing. Women whose most recent Pap test was (vs. was not) within the past year and women who ever (vs. never) had an abnormal Pap test were less willing to extend the screening interval. Additionally, women who typically saw an obstetrician/gynecologist or nurse practitioner for their Pap test (vs. a family physician) were less accepting of the guidelines. Hesitancy about the longer screening interval appears to stem from concern about developing cancer between screenings. Findings contribute to the growing body of research on cancer overscreening and may inform interventions for improving adherence to cancer screening guidelines.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer screening; Cervical cancer; HPV DNA tests; Health services overuse; Pap smear

Mesh:

Year:  2016        PMID: 27932055     DOI: 10.1016/j.ypmed.2016.11.028

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  7 in total

1.  Examining Changes in Prevention Guidelines in Maternal and Child Health: Development of a Teaching Activity.

Authors:  Erika L Thompson; Cheryl A Vamos; Amber Windsor-Hardy; Stacey B Griner; Ellen M Daley
Journal:  Matern Child Health J       Date:  2018-09

2.  Pre-Procedural Anxiety and Associated Factors Among Women Seeking for Cervical Cancer Screening Services in Shenzhen, China: Does Past Screening Experience Matter?

Authors:  Wei Lin; Weikang Huang; Chaofan Mei; Chuyan Zhong; Leilei Zhu; Peiyi Liu; Shixin Yuan; Zhihua Liu; Yueyun Wang
Journal:  Front Oncol       Date:  2022-07-06       Impact factor: 5.738

3.  Primary HPV testing recommendations of US providers, 2015.

Authors:  Crystale Purvis Cooper; Mona Saraiya
Journal:  Prev Med       Date:  2017-12       Impact factor: 4.018

4.  How Is Health Literacy Related to Pap Testing Among US Women?

Authors:  Erika L Thompson; Christopher W Wheldon; Cheryl A Vamos; Stacey B Griner; Ellen M Daley
Journal:  J Cancer Educ       Date:  2019-08       Impact factor: 2.037

5.  Human papillomavirus-based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial.

Authors:  Anna Gottschlich; Lovedeep Gondara; Laurie W Smith; Darrel Cook; Ruth Elwood Martin; Marette Lee; Stuart Peacock; Lily Proctor; Gavin Stuart; Mel Krajden; Eduardo L Franco; Dirk van Niekerk; Gina Ogilvie
Journal:  Int J Cancer       Date:  2022-05-10       Impact factor: 7.316

6.  Changing Preferences for a Cervical Cancer Screening Strategy: Moving Away from Annual Testing.

Authors:  Elizabeth Schrier; Hunter K Holt; Miriam Kuppermann; George F Sawaya
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-08-04

Review 7.  Factors associated with cervical cancer screening participation among migrant women in Europe: a scoping review.

Authors:  Patrícia Marques; Mariana Nunes; Maria da Luz Antunes; Bruno Heleno; Sónia Dias
Journal:  Int J Equity Health       Date:  2020-09-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.